Report overview
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine. This report contains market size and forecasts of Hepatitis A Vaccine in global, including the following market information:
Global Hepatitis A Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis A Vaccine Market Sales, 2018-2023, 2024-2029, (K Unit)
Global top five Hepatitis A Vaccine companies in 2022 (%)
The global Hepatitis A Vaccine market was valued at US$ 726.3 million in 2022 and is projected to reach US$ 842.5 million by 2029, at a CAGR of 2.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%.
Asia-Pacific is the largest market, with a share over 35%, followed by North America and Europe , both have a share over 55 percent.
In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
We surveyed the Hepatitis A Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis A Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, by Type, 2022 (%)
Inactivated Vaccine
Live Attenuated Vaccine
Global Hepatitis A Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Hepatitis A Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis A Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis A Vaccine revenues share in global market, 2022 (%)
Key companies Hepatitis A Vaccine sales in global market, 2018-2023 (Estimated), (K Unit)
Key companies Hepatitis A Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis A Vaccine, market overview.
Chapter 2: Global Hepatitis A Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis A Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
